PGEN vs CSQR Comparison

Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.

Csquare Inc is an enterprise digital infrastructure platform, owning and operating a geographically diverse portfolio of carrier-neutral data centers located across the United States, Canada and the United Kingdom. The company provides carrier-neutral colocation and interconnection services that provide infrastructure, including space, power, cooling systems, physical security, and interconnection capabilities, enabling customers to deploy and operate IT and network infrastructure. Its facilities support enterprise, network, cloud, and technology customers in the deployment and operation of IT and network infrastructure. The company generates the majority of its revenue from enterprise colocation services, which include fees for the licensing of cabinet space and power.